Crossmark

Ten years experience with the first approved biosimilar recombinant human growth hormone drug in normal clinical practice

Crossref DOI link: https://doi.org/10.1016/j.anpede.2017.03.021

Published Print: 2018-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

López-Siguero, Juan Pedro

Palla García, Margarida

Martínez Busto, Elena

Rebollo, Francisco José

Pombo, Manuel
License Information

Text and Data Mining valid from 2018-04-01
More Information

This article is maintained by: Elsevier

Article Title: Ten years experience with the first approved biosimilar recombinant human growth hormone drug in normal clinical practice

Journal Title: Anales de Pediatría (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.anpede.2017.03.021

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.anpedi.2017.03.007

Content Type: article

Copyright: © 2016 Asociación Española de Pediatría. Published by Elsevier España, S.L.U. All rights reserved.